A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy

The chemotherapeutics sorafenib and regorafenib inhibit shedding of MHC class I-related chain A (MICA) from hepatocellular carcinoma (HCC) cells by suppressing a disintegrin and metalloprotease 9 (ADAM9). MICA is a ligand for natural killer (NK) group 2 member D (NKG2D) and is expressed on tumor cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Sooyeon, Park, YoungJoon, Lee, Hyun-Jung, Lee, Jooho, Lee, Soo-Hyeon, Baek, Young-Seok, Chun, Su-Kyung, Lee, Seung-Min, Kim, Mina, Chon, Young-Eun, Ha, Yeonjung, Cho, Yuri, Kim, Gi Jin, Hwang, Seong-Gyu, Kwack, KyuBum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140088/
https://www.ncbi.nlm.nih.gov/pubmed/32245188
http://dx.doi.org/10.3390/cancers12030745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140088/
https://www.ncbi.nlm.nih.gov/pubmed/32245188
http://dx.doi.org/10.3390/cancers12030745

Ejemplares similares